Helping Serious Investors
Build Sustainable Wealth,The Right Way — With Skin in the Game
LNPR Capital is an independent equity research firm. We offer subscription-based equity research. Unlike others, we believe in "Skin in the Game" — we invest in every stock we publish reports on. Your trust is our greatest responsibility.
Regulatory Details
SEBI Reg No: INH000012953
BSE Enlistment: 5843
GST No: 19AAKFL6398J1ZG
Investment in markets
Securities market investments are subject to market risks. Read all documents carefully before investing.
An Independent Research House Built on Integrity
LNPR Capital is a team of dedicated investment enthusiasts with deep roots in Indian equity markets. We are a SEBI-registered research analyst firm offering subscription-based equity research to serious investors.
We are not brokers. We are not distributors. We are pure researchers — and we put our money where our recommendations are. Every stock in our research portfolio is one we hold ourselves, making our interests perfectly aligned with yours.
Our mission is to help retail investors make educated, data-backed, long-term investment decisions in small and mid-cap companies — the segment most ignored by institutional research, and most rewarding for patient investors.
What Makes Us Different
Principles that define how we think, research, and serve our clients.
Skin in the Game
We invest in every stock we recommend. Our money is at stake too, making our interests completely aligned with yours. No conflicts. No empty calls.
Only Data-Backed Ideas
Every recommendation is backed by rigorous quantitative and qualitative analysis. We believe: "In God we trust, all others must bring data."
Your Capital, Your Control
Your funds always remain securely in your own bank account and demat account. You retain complete ownership and decision-making authority, while we serve only as your trusted advisor — never a custodian.
Deep Fundamental Research
Our analysts go beyond screeners. On-ground research, management meetings, and forensic financial analysis inform every report we publish.
Exit is Important
Each investment is actively monitored, and we provide timely exit recommendations whenever the fundamentals change.
Explore Our Research Products
Choose the product that aligns with your investment goals and risk appetite. Start your journey toward financial empowerment today.
Small & Micro Cap
Focused. Research-driven. High-growth potential.
- →Market Cap: ₹100 Cr – ₹5,000 Cr
- →Ideas: 12–15 high-conviction research ideas annually
- →Research: Comprehensive, in-depth reports on every idea
- →Holding Period: 1–2 years
- →Active Tracking: Clear exit calls provided on every position
- →Access: Subscriber-only portal & email delivery
SME Master Club
Disciplined. Research-backed. Growth-focused.
- →Market Cap: ₹100 Cr – ₹2,000 Cr
- →Ideas: 20–25 high-conviction research ideas annually
- →Research: Detailed, comprehensive SME-focused reports
- →Holding Period: ~1 year
- →Support: Timely exit calls with thesis update notes
- →Access: Subscriber-only portal & priority support
Case Studies
Ashapura Minechem Limited
Reco Price: ₹370 / share · Exited at ₹730 / share
A global mineral leader with operations across 90+ countries and top-3 positions in bentonite and bleaching clay. The company’s growth is driven by its Guinea bauxite operations contributing ~76% of revenue. However, the investment case depends heavily on volume growth offsetting declining bauxite prices, making it a high-risk, high-upside commodity play.
Stallion India Fluorochemicals Limited
Reco Price: ₹150 / share · Exited at ₹405 / share
A near debt-free fluorochemical company benefiting from India's AC penetration boom. It operates as a refrigerant blending and distribution player with strong ROCE and margins. However, the long-term investment thesis depends on its ability to transition from HFCs to next-gen HFO refrigerants amid regulatory phase-down risks.
Guided by Experience. Driven by Discipline
Principles shaped by years of investing — lessons learned and shared with honesty.
Risk Before Returns
Long-term wealth is built through risk discipline and thoughtful allocation, not just stock selection.
Boring Compounds Best
Many of the greatest wealth creators are stable, unexciting businesses that grow steadily for decades.
Rejection Builds Wealth
Superior portfolios are shaped as much by what you avoid as by what you own.
Research Builds Conviction
Deep research enables investors to remain disciplined during volatility.
Investor Complaint Status
As required by SEBI, we disclose our investor complaints data monthly.
Investors Complaints Data — Month ending January 2026▾
| Sr. | Received from | Pending (prev. month) | Received | Resolved | Total Pending | Pending >3 months | Avg. Resolution (days) |
|---|---|---|---|---|---|---|---|
| 1 | Directly from Investors | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | SEBI (SCORES) | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | Other Sources | 0 | 0 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | 0 | 0 | |
* Inclusive of complaints of previous months resolved in the current month. # Inclusive of complaints pending as on the last day of the month.
Trend Of Monthly Disposal Of Complaints (April 2025 – March 2026)▾
| Sr. | Month | Carried Forward | Received | Resolved | Pending |
|---|---|---|---|---|---|
| 1 | April, 2025 | 0 | 0 | 0 | 0 |
| 2 | May, 2025 | 0 | 0 | 0 | 0 |
| 3 | June, 2025 | 0 | 0 | 0 | 0 |
| 4 | July, 2025 | 0 | 0 | 0 | 0 |
| 5 | August, 2025 | 0 | 0 | 0 | 0 |
| 6 | September, 2025 | 0 | 0 | 0 | 0 |
| 7 | October, 2025 | 0 | 0 | 0 | 0 |
| 8 | November, 2025 | 0 | 0 | 0 | 0 |
| 9 | December, 2025 | 0 | 0 | 0 | 0 |
| 10 | January, 2026 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | |
Trend Of Annual Disposal Of Complaints▾
| Sr. | Year | Carried Forward | Received | Resolved | Pending |
|---|---|---|---|---|---|
| 1 | 2024-2025 | 0 | 0 | 0 | 0 |
| 2 | 2023-2024 | NA | NA | NA | NA |
| 3 | 2022-2023 | NA | NA | NA | NA |
Frequently Asked Questions
Have questions about our research, subscription, or process? We believe in transparent communication — here are the questions we hear most often.
